Dehydration News and Research

Latest Dehydration News and Research

Easy ways to prevent dry skin

What do cleansers, alcohol and coffee have in common? They are the worst enemies of your skin during winter, sucking out the moisture from your skin and making it extremely dry and itchy.

11 Dec 2012

Tips to prevent ‘holiday heart’ syndrome

The holiday season is supposed to be joyous, fun and happy. But it can also be stressful. The nation's emergency physicians want to remind all Americans to keep your stress in check.

10 Dec 2012

Anti-seizure drug benefits women with severe morning sickness

Good news may be on the horizon for Kate Middleton, Duchess of Cambridge, and other women stricken with severe nausea and vomiting during pregnancy, thanks to the work of a University at Buffalo professor who is conducting research on a drug that is showing success treating pregnant women with this condition.

8 Dec 2012

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Novartis will highlight more than 140 presentations on key data from its extensive oncology portfolio at the leading year-end scientific meetings devoted to hematology and breast cancer, demonstrating continued innovation in research and development efforts to advance the care of patients with cancer and rare diseases.

30 Nov 2012

Have water throughout the day to prevent dehydration

Many people may have heard that on average our body weight is around 2/3 water of which 2.5 litres are lost daily. We get around 1 litre of water we need from our food but to balance the total loss the rest needs to be from the drinks we have. It's recommended to drink around 1.2 litres per day which is the equivalent of 8 x 150ml glasses.

15 Nov 2012

FDA accepts Sunovion’s two LATUDA sNDAs for review

Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review two supplemental New Drug Applications (sNDAs) for the use of LATUDA as 1) monotherapy and 2) adjunctive therapy to lithium or valproate, both to treat adult patients with depressive episodes associated with bipolar I disorder (bipolar depression).

31 Oct 2012

Winter safety tips for older adults

Winter is a special time for celebration. It should also be a time for added caution if you or someone in your family is an older adult. It is the season for falls, slips on icy streets and other dangers that can be especially harmful for older adults.

25 Oct 2012

Babies born to HIV positive mothers more likely to acquire measles

Non-infected babies born to HIV positive mothers should be vaccinated early against measles, to avoid them acquiring the virus or passing it on to others.

19 Oct 2012

Link between norovirus outbreaks and excess hospitalization and mortality in nursing homes

In a study that included more than 300 Medicare-certified nursing homes, rates of hospitalization and death were substantially increased during outbreaks of norovirus gastroenteritis vs. non-outbreak periods, according to a study appearing in the October 24/31 issue of JAMA.

19 Oct 2012

USPTO grants five-year extension to Spectrum's FOLOTYN patent

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that the United States Patent and Trademark Office (USPTO) has extended by five years the U.S. Patent No. 6,028,071, which covers FOLOTYN (pralatrexate injection).

8 Oct 2012

Biologists solve long-standing scientific mystery of how mice first know to nurse or suckle

A team led by biologists at The Scripps Research Institute has solved the long-standing scientific mystery of how mice first know to nurse or suckle.

5 Oct 2012

Nova Scotia's stroke strategy improves care for three rural health districts

Stroke patients in rural Nova Scotia receive better treatment and are less likely to end up in long-term care facilities than they were before the province's stroke strategy was rolled out in 2008, according to a study presented today at the Canadian Stroke Congress.

1 Oct 2012

Important data from Pfizer’s lung cancer and RCC portfolios to be presented at ESMO Congress

Pfizer Oncology today announced that important data from its lung cancer and renal cell carcinoma (RCC) portfolios will be presented at the upcoming European Society for Medical Oncology (ESMO) Congress in Vienna, Austria, September 28 - October 2, 2012.

18 Sep 2012

Parents of sickle cell babies undercounseled

Parents of newborns with the sickle cell anemia trait are significantly less likely to receive genetic counseling than those of babies who are cystic fibrosis carriers, say researchers.

17 Sep 2012

Risks of antidiabetic drug substantially overrated for patients with reduced kidney function

The antidiabetic drug metformin is not prescribed for patients with reduced kidney function because the risk of adverse effects has been regarded as unacceptably high. A study at Sahlgrenska Academy, University of Gothenburg, Sweden, has found that the risks have been substantially overrated. As a result, many more patients with diabetes may be able to enjoy the benefits of the medication.

17 Sep 2012

Drinking water fails to meet state quality standards at North Carolina migrant farmworker camps

The drinking water at one-third of migrant farmworker camps in eastern North Carolina failed to meet state quality standards, according to a new study from Wake Forest Baptist Medical Center.

15 Sep 2012

Parents of infants with cystic fibrosis carriers more likely to receive genetic counseling

Parents of newborns with the sickle cell anemia trait were less likely to receive genetic counseling than parents whose babies are cystic fibrosis carriers, a new study from the University of Michigan shows.

12 Sep 2012

EC grants European market authorization for Revestive to treat short bowel syndrome

Takeda Pharmaceutical Company Limited and NPS Pharmaceuticals, Inc., jointly announced today that the European Commission has granted European market authorization for the medicinal product teduglutide (trade name in Europe: Revestive) as a once-daily treatment for adult patients with short bowel syndrome.

5 Sep 2012

EC grants marketing authorization for Pfizer’s INLYTA to treat renal cell carcinoma

Pfizer Inc. announced today that the European Commission (EC) has granted marketing authorization for INLYTA (axitinib) for the treatment of adult patients with advanced renal cell carcinoma (RCC), a type of kidney cancer, after failure of prior treatment with sunitinib or a cytokine.

4 Sep 2012

FDA approves Novartis’ Exelon Patch to treat mild to moderate AD

The US Food and Drug Administration has approved a higher dose of Exelon Patch (rivastigmine transdermal system) for the treatment of people with mild to moderate Alzheimer's disease.

4 Sep 2012

Dehydration News and Research

Latest Dehydration News and Research

Easy ways to prevent dry skin

Tips to prevent ‘holiday heart’ syndrome

Anti-seizure drug benefits women with severe morning sickness

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Have water throughout the day to prevent dehydration

FDA accepts Sunovion’s two LATUDA sNDAs for review

Winter safety tips for older adults

Babies born to HIV positive mothers more likely to acquire measles

Link between norovirus outbreaks and excess hospitalization and mortality in nursing homes

USPTO grants five-year extension to Spectrum's FOLOTYN patent

Biologists solve long-standing scientific mystery of how mice first know to nurse or suckle

Nova Scotia's stroke strategy improves care for three rural health districts

Important data from Pfizer’s lung cancer and RCC portfolios to be presented at ESMO Congress

Parents of sickle cell babies undercounseled

Risks of antidiabetic drug substantially overrated for patients with reduced kidney function

Drinking water fails to meet state quality standards at North Carolina migrant farmworker camps

Parents of infants with cystic fibrosis carriers more likely to receive genetic counseling

EC grants European market authorization for Revestive to treat short bowel syndrome

EC grants marketing authorization for Pfizer’s INLYTA to treat renal cell carcinoma

FDA approves Novartis’ Exelon Patch to treat mild to moderate AD

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Dehydration News and Research

Latest Dehydration News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in